Blockbuster merger between two drug giants imminent

US-based Pfizer in talks to buy Dublin based Allergan for as much as $380 a share

20th November, 2015
Deal could happen on Monday Pic: Getty

A mega merger between Pfizer and Allergan could come as early as Monday - valuing the Irish Botox-maker as high as $150bn.

US based Pfizer is understood to be in advanced talks to buy Dublin-domiciled Allergan for as much as $380 a share.

The proposed deal, still under negotiation, would probably see Pfizer redomicile in Ireland, where Allergan is registered and corporation taxes are much lower.

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader



Unlimited Access for 1 Month

Get basic

*New subscribers only

You can cancel any time.



€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.




90 Day Pass

You can cancel any time.

2 Yearly



Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

Tom Maguire: Tax changes we make now could help business for years

More Business Tom Maguire 10 months ago

The Daily Briefing

The Daily Briefing